New England Research & Management »

Regeneron Pharmaceuticals shares owned by New England Research & Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by New England Research & Management from 13F filings

Historical chart of New England Research & Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by New England Research & Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by New England Research & Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $386k 500 771.87
2025-06-30 $318k 605 525.62
2025-03-31 $384k 605 634.71
2023-06-30 $675k 940 718.09
2022-09-30 $642k 932 688.84
2022-06-30 $586k 991 591.32
2022-03-31 $661k 946 698.73
2021-12-31 $616k 975 631.79
2021-09-30 $372k 615 604.88
2021-06-30 $927k 1.7k 558.43
2021-03-31 $880k 1.9k 473.12
2020-12-31 $548k 1.1k 482.82
2020-09-30 $898k 1.6k 559.50
2016-12-31 $268k 730 367.12
2016-09-30 $344k 855 402.34
2016-06-30 $400k 1.1k 349.35
2016-03-31 $351k 975 360.00
2013-12-31 $688k 2.5k 275.42